Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MoreThe JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MoreThese are the stocks posting the largest moves in premarket trading. Source link
Read MoreShares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThe health care-focused hedge fund lists Yale University's endowment and the Tisch family among its clients. Source link
Read MoreCAR-T immunotherapies and antibody drug conjugates will highlight the American Society of Clinical Oncology's cancer research conference that starts Thursday.
Read MoreNames on the move ahead of the open. Source link
Read MoreNames on the move ahead of the open. Source link
Read MoreNames on the move ahead of the open. Source link
Read More